These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 17965059)

  • 1. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
    Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
    Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled trial of itopride in functional dyspepsia.
    Holtmann G; Talley NJ; Liebregts T; Adam B; Parow C
    N Engl J Med; 2006 Feb; 354(8):832-40. PubMed ID: 16495395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia.
    Amarapurkar DN; Rane P
    J Indian Med Assoc; 2004 Dec; 102(12):735-7, 760. PubMed ID: 15871365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia.
    Sawant P; Das HS; Desai N; Kalokhe S; Patil S
    J Assoc Physicians India; 2004 Aug; 52():626-8. PubMed ID: 15847356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of itopride in the symptoms of functional dyspepsia in Russia: results of a phase IV prospective open-label multicenter clinical trial].
    Kas'ianenko VI; Denisov NL; Vasil'ev IuV
    Ter Arkh; 2014; 86(8):35-41. PubMed ID: 25306742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study.
    Sun J; Yuan YZ; Holtmann G
    Clin Drug Investig; 2011 Dec; 31(12):865-75. PubMed ID: 22035464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials.
    Vakil N; Laine L; Talley NJ; Zakko SF; Tack J; Chey WD; Kralstein J; Earnest DL; Ligozio G; Cohard-Radice M
    Am J Gastroenterol; 2008 Aug; 103(8):1906-19. PubMed ID: 18616658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
    Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T
    Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia.
    Tack J; Masclee A; Heading R; Berstad A; Piessevaux H; Popiela T; Vandenberghe A; Kato H
    Neurogastroenterol Motil; 2009 Mar; 21(3):272-80. PubMed ID: 19254354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study.
    Braak B; Klooker TK; Wouters MM; Lei A; van den Wijngaard RM; Boeckxstaens GE
    Aliment Pharmacol Ther; 2011 Sep; 34(6):638-48. PubMed ID: 21767283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of itopride hydrochloride in patients with non-ulcer dyspepsia.
    Shenoy KT; Veenasree ; Leena KB
    J Indian Med Assoc; 2003 Jun; 101(6):387-8. PubMed ID: 14579989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study.
    von Arnim U; Peitz U; Vinson B; Gundermann KJ; Malfertheiner P
    Am J Gastroenterol; 2007 Jun; 102(6):1268-75. PubMed ID: 17531013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study.
    Kupcinskas L; Lafolie P; Lignell A; Kiudelis G; Jonaitis L; Adamonis K; Andersen LP; Wadström T
    Phytomedicine; 2008 Jun; 15(6-7):391-9. PubMed ID: 18467083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A randomized controlled Multi-center clinical trial on mosapride in the treatment of functional dyspepsia].
    Chen SY; Wang JY; Zhu CW; Yuan YZ; Zou B; Xia L; Liu JY; Xu HW; Zhang SZ; Wang Q; Xie XJ; Zhao ZQ; Lin L; Hu NZ; Xu JM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):165-8. PubMed ID: 15132875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of the placebo response in functional dyspepsia.
    Talley NJ; Locke GR; Lahr BD; Zinsmeister AR; Cohard-Radice M; D'Elia TV; Tack J; Earnest DL
    Aliment Pharmacol Ther; 2006 Apr; 23(7):923-36. PubMed ID: 16573795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of new gastro-intestinal prokinetic (ENGIP-II) study.
    Walwaikar PP; Kulkarni SS; Bargaje RS
    J Indian Med Assoc; 2005 Dec; 103(12):708-9. PubMed ID: 16821670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tegaserod in patients with mechanical sensitivity and overlapping symptoms of functional heartburn and functional dyspepsia.
    Miner PB; Rodriguez-Stanley S; Proskin HM; Kianifard F; Bottoli I
    Curr Med Res Opin; 2008 Aug; 24(8):2159-72. PubMed ID: 18561877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers.
    Choung RS; Talley NJ; Peterson J; Camilleri M; Burton D; Harmsen WS; Zinsmeister AR
    Neurogastroenterol Motil; 2007 Mar; 19(3):180-7. PubMed ID: 17300287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.